TCIM
TIAA CREF Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $528K | Buy |
100,555
+32,043
| +47% | +$168K | ﹤0.01% | 2578 |
|
|
2018
Q4 | $305K | Buy |
68,512
+35,200
| +106% | +$157K | ﹤0.01% | 2767 |
|
|
2018
Q3 | $269K | Buy |
33,312
+3,503
| +12% | +$28.3K | ﹤0.01% | 2913 |
|
|
2018
Q2 | $209K | Sell |
29,809
-68,230
| -70% | -$478K | ﹤0.01% | 3028 |
|
|
2018
Q1 | $1.4M | Buy |
98,039
+44,655
| +84% | +$635K | ﹤0.01% | 2280 |
|
|
2017
Q4 | $468K | Buy |
53,384
+3,304
| +7% | +$29K | ﹤0.01% | 2802 |
|
|
2017
Q3 | $586K | Buy |
50,080
+596
| +1% | +$6.97K | ﹤0.01% | 2766 |
|
|
2017
Q2 | $691K | Buy |
49,484
+26,560
| +116% | +$371K | ﹤0.01% | 2716 |
|
|
2017
Q1 | $315K | Buy |
22,924
+6,091
| +36% | +$83.7K | ﹤0.01% | 2915 |
|
|
2016
Q4 | $121K | Buy |
16,833
+6,073
| +56% | +$43.7K | ﹤0.01% | 3077 |
|
|
2016
Q3 | $163 | Sell |
10,760
-539
| -5% | -$8 | ﹤0.01% | 3066 |
|
|
2016
Q2 | $111K | Buy |
+11,299
| New | +$111K | ﹤0.01% | 3129 |
|